Select for export Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-025-03654-3 PubMed 41173871 Copy citation Copy BibTeX Unknown journal 2025-10-30 d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM Europe PMC Published psilocybin DepressionAnxietyBrain Imaging Systematic Review More
Select for export Psilocybin use in bipolar disorder: A comprehensive review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2025.120485 PubMed 41177271 Copy citation Copy BibTeX Unknown journal 2025-10-30 Do A, Cloutier L, Hébert-Tremblay L, Thauvin C. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-10-29 Ohio State University ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionAnxietyNeuroplasticity Clinical Trial More
Select for export Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopha.2025.118720 PubMed 41172953 Copy citation Copy BibTeX Biomedicine & Pharmacotherapy 2025-10-29 Rubén García-Cabrerizo, Itziar Beruete-Fresnillo, Pedro Bergas-Cladera, M. Julia García-Fuster OpenAlex Published psilocybin DepressionNeuroplasticityNeurogenesis Observational Study More
Select for export A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)? Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-10-28 Anna Rose Childress, Ph.D. ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAddictionOCD Clinical Trial More
Select for export Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Abstract available at the source but not redistributed here. Read at source. Details DOI 10.61373/pp025i.0044 Copy citation Copy BibTeX Psychedelics. 2025-10-27 James J Gattuso, Bilgenur Bezcioglu, Carey Wilson, Kato Havaux, Anthony J. Hannan, Thibault Renoir OpenAlex Published psilocybinpsilocin DepressionAnxietyOCD Randomized Controlled Trial More
Select for export Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pnpbp.2025.111541 PubMed 41138900 Copy citation Copy BibTeX Unknown journal 2025-10-22 Bukovsky D, Amaev A, Song J, Kyte S, Carmona-Torres E, Ueno F Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export Psychedelics and time: Exploring altered temporal perception and its implications for consciousness, neuroscience, and therapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.61373/pp025p.0041 Copy citation Copy BibTeX Psychedelics. 2025-10-20 Pu Jiang, Cong Lin, Xiaohui Wang OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Is there more to magic mushrooms than psilocybin? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/cen-10322-feature2 Copy citation Copy BibTeX C&EN Global Enterprise 2025-10-19 special to C EN Mara Johnson-Groh OpenAlex Published psilocybinpsilocin DepressionAddictionOCD Clinical Trial More
Select for export Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20451253251384513 PubMed 41122434 Copy citation Copy BibTeX Unknown journal 2025-10-15 Wong S, Jones BDM, Thiyagarajah MT, Sabbah SG, Thompson C, Solmi M Europe PMC Published psilocybin DepressionBrain ImagingMechanism of Action Systematic Review More
Select for export Structure-GuidedDesign of Novel 5-HT2A Partial Agonists as PsychedelicAnalogues with Antidepressant Effects Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acs.jmedchem.5c02045.s001 Copy citation Copy BibTeX Figshare 2025-10-14 Rongyan Li (11403789), Haohan Yan (22432650), Yujin Chen (1412254), Yangyang Liu (807797), Lingjie Tang (9276407), Jing Yu (81085) OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Animal Study More
Select for export Psilocybin exerts differential effects on social behaviour and inflammation in mice in contexts of activity-based anorexia (ABA) Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2025.10.14.682467 Copy citation Copy BibTeX bioRxiv 2025-10-14 Shadani S, Greaves E, Andrews ZB, Foldi CJ. bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyOCD Animal Study More
Select for export Psychedelics in the context of stress and psychiatric disorders: A new horizon in mental health treatment Abstract available at the source but not redistributed here. Read at source. Details DOI 10.61373/pp025v.0038 Copy citation Copy BibTeX Psychedelics. 2025-10-13 Sha Jin, H.Y. Wang, Xiaohui Wang OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Psilocybin and Affective Function in Chronic Lower Back Pain Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-10-13 Johns Hopkins University ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionChronic PainMechanism of Action Observational Study More
Select for export Structure-Guided Design of Novel 5-HT2A Partial Agonists as Psychedelic Analogues with Antidepressant Effects Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acs.jmedchem.5c02045 PubMed 41087124 Copy citation Copy BibTeX Journal of Medicinal Chemistry 2025-10-13 Rongyan Li, Haohan Yan, Yujin Chen, Yangyang Liu, Lingjie Tang, Jing Yu OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Animal Study More
Select for export Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acschemneuro.5c00667 PubMed 41078264 Copy citation Copy BibTeX ACS Chemical Neuroscience 2025-10-12 Rajiv Agrawal, Daniel J. Gillie, Alison E. Mungenast, Milan Chytil, Sharon Engel, Michael C. Wu OpenAlex Published psilocybin DepressionAddictionNeuroplasticity Animal Study More
Select for export Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.genhosppsych.2025.10.010 PubMed 41109203 Copy citation Copy BibTeX General Hospital Psychiatry 2025-10-10 Yvan Beaussant, Elise C. Tarbi, Kabir Nigam, Skye A. Miner, Zachary Sager, Justin J. Sanders OpenAlex Published psilocybin DepressionChronic PainToxicity Qualitative Study More
Select for export Psychedelics in Practice: Science, Safety, and the Future of Healing Abstract available at the source but not redistributed here. Read at source. Details DOI 10.54389/epsd8792 Copy citation Copy BibTeX The proceedings of sliit international conference on advancements in science and humanities 2025-10-09 Renee Ireland OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Control group improvement lower in psilocybin trials for depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pu.31371 Copy citation Copy BibTeX The Brown University Psychopharmacology Update 2025-10-09 Authors unavailable OpenAlex Published psilocybin DepressionReceptor PharmacologyClinical Trial Randomized Controlled Trial More
Select for export Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532]. No abstract availability was recorded for this entry. Details DOI 10.1016/j.jad.2025.120352 PubMed 41075579 Copy citation Copy BibTeX Unknown journal 2025-10-09 Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Chai-Rees J, Croal M Europe PMC Published psilocybin DepressionTreatment-Resistant Depression Other More
